Diabetes, Vol 47, Issue 9 1412-1418, Copyright © 1998 by American Diabetes Association

ARTICLES

Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels

FM Gribble, SJ Tucker, S Seino and FM Ashcroft
University Laboratory of Physiology, Oxford, England, UK.

Sulfonylureas stimulate insulin secretion from pancreatic beta-cells by closing ATP-sensitive K+ (K(ATP)). The beta-cell and cardiac muscle K(ATP) channels have recently been cloned and shown to possess a common pore-forming subunit (Kir6.2) but different sulfonylurea receptor subunits (SUR1 and SUR2A, respectively). We examined the mechanism underlying the tissue specificity of the sulfonylureas tolbutamide and glibenclamide, and the benzamido-derivative meglitinide, using cloned beta-cell (Kir6.2/SUR1) and cardiac (Kir6.2/SUR2A) K(ATP) channels expressed in Xenopus oocytes. Tolbutamide inhibited Kir6.2/SUR1 (Ki approximately 5 micromol/l), but not Kir6.2/SUR2A, currents with high affinity. Meglitinide produced high-affinity inhibition of both Kir6.2/SUR1 and Kir6.2/SUR2A currents (Kis approximately 0.3 micromol/l and approximately 0.5 micromol/l, respectively). Glibenclamide also blocked Kir6.2/SUR1 and Kir6.2/SUR2A currents with high affinity (Kis approximately 4 nmol/l and approximately 27 nmol/l, respectively); however, only for cardiac-type K(ATP) channels was this block reversible. Physiological concentrations of MgADP (100 micromol/l) enhanced glibenclamide inhibition of Kir6.2/SUR1 currents but reduced that of Kir6.2/SUR2A currents. The results suggest that SUR1 may possess separate high-affinity binding sites for sulfonylurea and benzamido groups. SUR2A, however, either does not possess a binding site for the sulfonylurea group or is unable to translate the binding at this site into channel inhibition. Although MgADP reduces the inhibitory effect of glibenclamide on cardiac-type K(ATP) channels, drugs that bind to the common benzamido site have the potential to cause side effects on the heart.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Winkler, D. Stephan, S. Bieger, P. Kuhner, F. Wolff, and U. Quast Testing the Bipartite Model of the Sulfonylurea Receptor Binding Site: Binding of A-, B-, and A + B-Site Ligands J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 701 - 708. [Abstract] [Full Text] [PDF]

				P. Tammaro and F. Ashcroft The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits J. Physiol., June 15, 2007; 581(3): 1259 - 1269. [Abstract] [Full Text] [PDF]

				S. Nagamatsu, M. Ohara-Imaizumi, Y. Nakamichi, T. Kikuta, and C. Nishiwaki Imaging docking and fusion of insulin granules induced by antidiabetes agents: sulfonylurea and glinide drugs preferentially mediate the fusion of newcomer, but not previously docked, insulin granules. Diabetes, October 1, 2006; 55(10): 2819 - 2825. [Abstract] [Full Text] [PDF]

				H.-S. Sun, Z.-P. Feng, T. Miki, S. Seino, and R. J. French Enhanced Neuronal Damage After Ischemic Insults in Mice Lacking Kir6.2-Containing ATP-Sensitive K+ Channels J Neurophysiol, April 1, 2006; 95(4): 2590 - 2601. [Abstract] [Full Text] [PDF]

				P. Tammaro, P. Proks, and F. M. Ashcroft Functional effects of naturally occurring KCNJ11 mutations causing neonatal diabetes on cloned cardiac KATP channels J. Physiol., February 15, 2006; 571(1): 3 - 14. [Abstract] [Full Text] [PDF]

				M. L. Evans, R. J. McCrimmon, D. E. Flanagan, T. Keshavarz, X. Fan, E. C. McNay, R. J. Jacob, and R. S. Sherwin Hypothalamic ATP-sensitive K + Channels Play a Key Role in Sensing Hypoglycemia and Triggering Counterregulatory Epinephrine and Glucagon Responses Diabetes, October 1, 2004; 53(10): 2542 - 2551. [Abstract] [Full Text] [PDF]

				K. Shimomura, H. Shimizu, M. Ikeda, S. Okada, M. Kakei, S. Matsumoto, and M. Mori Fenofibrate, Troglitazone, and 15-Deoxy-{Delta}12,14-prostaglandin J2 Close KATP Channels and Induce Insulin Secretion J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1273 - 1280. [Abstract] [Full Text] [PDF]

				G. E. Billman, M. S. Houle, H. C. Englert, and H. Gogelein J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 182 - 192. [Abstract] [Full Text]

				S. Clement, S. S. Braithwaite, M. F. Magee, A. Ahmann, E. P. Smith, R. G. Schafer, and I. B. Hirsch Management of Diabetes and Hyperglycemia in Hospitals Diabetes Care, February 1, 2004; 27(2): 553 - 591. [Full Text] [PDF]

				K.-H. Park and T. Akaike Visualization of the Specific Interaction of Sulfonylurea-Incorporated Polymer with Insulinoma Cell Line MIN6 J. Biochem., February 1, 2004; 135(2): 179 - 183. [Abstract] [Full Text] [PDF]

				T. G. J. Allen and D. A. Brown Modulation of the excitability of cholinergic basal forebrain neurones by KATP channels J. Physiol., January 15, 2004; 554(2): 353 - 370. [Abstract] [Full Text] [PDF]

				J J Meier, B Gallwitz, W E Schmidt, A Mugge, and M A Nauck Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important? Heart, January 1, 2004; 90(1): 9 - 12. [Abstract] [Full Text] [PDF]

				M. Chachin, M. Yamada, A. Fujita, T. Matsuoka, K. Matsushita, and Y. Kurachi Nateglinide, a D-Phenylalanine Derivative Lacking Either a Sulfonylurea or Benzamido Moiety, Specifically Inhibits Pancreatic beta -Cell-Type KATP Channels J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1025 - 1032. [Abstract] [Full Text] [PDF]

				P. Proks, F. Reimann, N. Green, F. Gribble, and F. Ashcroft Sulfonylurea Stimulation of Insulin Secretion Diabetes, December 1, 2002; 51(90003): S368 - 376. [Abstract] [Full Text] [PDF]

				J. D. Lippiat, S. L. Albinson, and F. M. Ashcroft Interaction of the Cytosolic Domains of the Kir6.2 Subunit of the KATP Channel Is Modulated by Sulfonylureas Diabetes, December 1, 2002; 51(90003): S377 - 380. [Abstract] [Full Text] [PDF]

				U. Lange, C. Loffler-Walz, H. C. Englert, A. Hambrock, U. Russ, and U. Quast The Stereoenantiomers of a Pinacidil Analog Open or Close Cloned ATP-sensitive K+ Channels J. Biol. Chem., October 18, 2002; 277(43): 40196 - 40205. [Abstract] [Full Text] [PDF]

				A. M. K. Hansen, I. T. Christensen, J. B. Hansen, R. D. Carr, F. M. Ashcroft, and P. Wahl Differential Interactions of Nateglinide and Repaglinide on the Human {beta}-Cell Sulphonylurea Receptor 1 Diabetes, September 1, 2002; 51(9): 2789 - 2795. [Abstract] [Full Text] [PDF]

				A.-A. Konstas, M. Dabrowski, C. Korbmacher, and S. J. Tucker Intrinsic Sensitivity of Kir1.1 (ROMK) to Glibenclamide in the Absence of SUR2B. IMPLICATIONS FOR THE IDENTITY OF THE RENAL ATP-REGULATED SECRETORY K+ CHANNEL J. Biol. Chem., June 7, 2002; 277(24): 21346 - 21351. [Abstract] [Full Text] [PDF]

				J. P. Giblin, Y. Cui, L. H. Clapp, and A. Tinker Assembly Limits the Pharmacological Complexity of ATP-sensitive Potassium Channels J. Biol. Chem., April 12, 2002; 277(16): 13717 - 13723. [Abstract] [Full Text] [PDF]

				J. D. Tune, C. Yeh, S. Setty, and H. F. Downey ATP-Dependent K+ Channels Contribute to Local Metabolic Coronary Vasodilation in Experimental Diabetes Diabetes, April 1, 2002; 51(4): 1201 - 1207. [Abstract] [Full Text] [PDF]

				F. Reimann, F. M. Ashcroft, and F. M. Gribble Structural Basis for the Interference Between Nicorandil and Sulfonylurea Action Diabetes, October 1, 2001; 50(10): 2253 - 2259. [Abstract] [Full Text]

				M. Okamura, M. Kakei, K. Ichinari, A. Miyamura, N. Oketani, N. Koriyama, and C. Tei State-dependent modification of ATP-sensitive K+ channels by phosphatidylinositol 4,5-bisphosphate Am J Physiol Cell Physiol, February 1, 2001; 280(2): C303 - C308. [Abstract] [Full Text] [PDF]

				D.J. Betteridge and L. Close Diabetes, coronary heart disease and sulphonylureas--not the final word Eur. Heart J., May 2, 2000; 21(10): 790 - 792. [PDF]

				S. Hu, S. Wang, and B. E. Dunning Tissue Selectivity of Antidiabetic Agent Nateglinide: Study on Cardiovascular and beta -Cell KATP Channels J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1372 - 1379. [Abstract] [Full Text]

				I. Gross, A. Toman, I. Uhde, C. Schwanstecher, and M. Schwanstecher ACCELERATED COMMUNICATION: Stoichiometry of Potassium Channel Opener Action Mol. Pharmacol., December 1, 1999; 56(6): 1370 - 1373. [Abstract] [Full Text]

				I. Uhde, A. Toman, I. Gross, C. Schwanstecher, and M. Schwanstecher Identification of the Potassium Channel Opener Site on Sulfonylurea Receptors J. Biol. Chem., October 1, 1999; 274(40): 28079 - 28082. [Abstract] [Full Text] [PDF]

				H. Dörschner, I. Uhde, C. Schwanstecher, and M. Schwanstecher Stoichiometry of Sulfonylurea-Induced ATP-Sensitive Potassium Channel Closure Mol. Pharmacol., June 1, 1999; 55(6): 1060 - 1066. [Abstract] [Full Text]

				D.-K. Song and F. M. Ashcroft ATP Modulation of ATP-sensitive Potassium Channel ATP Sensitivity Varies with the Type of SUR Subunit J. Biol. Chem., March 2, 2001; 276(10): 7143 - 7149. [Abstract] [Full Text] [PDF]